Asset Details
Do you wish to reserve the book?
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
Do you wish to request the book?
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
2020
Overview
The lung is a key target of the cytokine storm that can be triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the widespread clinical syndrome known as coronavirus disease 2019 (COVID-19). Indeed, in some patients, SARS-CoV-2 promotes a dysfunctional immune response that dysregulates the cytokine secretory pattern. Hypercytokinemia underlies the hyperinflammatory state leading to injury of alveolar epithelial cells and vascular endothelial cells, as well as to lung infiltration sustained by neutrophils and macrophages. Within such a pathogenic context, interleukin-6 (IL-6) and other cytokines/chemokines play a pivotal pro-inflammatory role. Therefore, cytokines and their receptors, as well as cytokine-dependent intracellular signalling pathways can be targeted by potential therapies aimed to relieve the heavy burden of cytokine storm. In particular, the anti-IL-6-receptor monoclonal antibody tocilizumab is emerging as one of the most promising pharmacologic treatments.
The reviews of this paper are available via the supplemental material section.
Publisher
SAGE Publications,SAGE PUBLICATIONS, INC,SAGE Publishing
Subject
Antibodies, Monoclonal, Humanized - therapeutic use
/ Coronavirus Infections - drug therapy
/ Coronavirus Infections - immunology
/ Coronavirus Infections - metabolism
/ COVID-19
/ Endothelial Cells - metabolism
/ Humans
/ Pneumonia, Viral - drug therapy
/ Pneumonia, Viral - immunology
/ Pneumonia, Viral - metabolism
/ Review
